Effect of clinical pharmacist encounters in the transitional care clinic on 30-day re-admissions: A retrospective study.
30-day re-admission
affordable care act (ACC)
clinical pharmacist (CP)
electronic medical record (EMR)
transitional-care clinic (TCC)
Journal
AIMS public health
ISSN: 2327-8994
Titre abrégé: AIMS Public Health
Pays: United States
ID NLM: 101635098
Informations de publication
Date de publication:
2019
2019
Historique:
received:
20
06
2019
accepted:
17
09
2019
entrez:
23
10
2019
pubmed:
23
10
2019
medline:
23
10
2019
Statut:
epublish
Résumé
Hospitalized patients who meet specific criteria at discharge are referred to the transitional care clinic team consisting of a nurse practitioner and/or physician and a clinical pharmacist. In collaboration with the providers, the pharmacist reviews medications for appropriateness, assesses adherence, recommends medication changes and provides education. The purpose of this study was to measure the effect of an outpatient transitional care clinical pharmacist on 30-day re-admissions in an urban setting serving a population of low socioeconomic status. After receiving IRB approval, this single-center retrospective study analyzed records of 573 patient visits of which nearly 75% included a clinical pharmacist interaction. Rates of 30-day re-admissions were not statistically different among the two groups, however, it was found that each added co-morbidity significantly increased the patients' 30-day re-admission rate by 26%.
Identifiants
pubmed: 31637283
doi: 10.3934/publichealth.2019.3.345
pii: publichealth-06-03-345
pmc: PMC6779605
doi:
Types de publication
Journal Article
Langues
eng
Pagination
345-354Informations de copyright
© 2019 the Author(s), licensee AIMS Press.
Déclaration de conflit d'intérêts
Conflict of interest: All authors declare no conflicts of interest in this paper.
Références
Thorax. 2019 Nov;74(11):1046-1054
pubmed: 29622692
Hosp Pharm. 2015 Sep;50(8):700-9
pubmed: 26823619
J Am Pharm Assoc (2003). 2018 Sep - Oct;58(5):554-560
pubmed: 30017370
Aust Health Rev. 2004 Dec 13;28(3):275-84
pubmed: 15595909
BMJ Open. 2016 Feb 23;6(2):e010003
pubmed: 26908524
Am J Health Syst Pharm. 2018 May 15;75(10):613-621
pubmed: 29650726
Ann Fam Med. 2015 Mar;13(2):115-22
pubmed: 25755032
Am J Health Syst Pharm. 2014 Jan 15;71(2):134-9
pubmed: 24375606
Am J Health Syst Pharm. 2015 Jun 1;72(11 Suppl 1):S36-42
pubmed: 25991594
Dimens Crit Care Nurs. 2017 Nov/Dec;36(6):311-316
pubmed: 28976480
Hosp Pharm. 2016 Dec;51(11):907-914
pubmed: 28057950
Am J Manag Care. 2017 Mar;23(3):170-176
pubmed: 28385023
J Am Pharm Assoc (2003). 2018 Sep - Oct;58(5):540-546
pubmed: 30017369
Hosp Pharm. 2016 Oct;51(9):744-751
pubmed: 27803504
Eur J Intern Med. 2013 Dec;24(8):779-83
pubmed: 24055382
J Pharm Pract. 2019 Feb;32(1):68-76
pubmed: 29183253
J Pharm Technol. 2015 Apr;31(2):64-68
pubmed: 34860866
Am J Manag Care. 2015 Feb;21(2):106-13
pubmed: 25880360
Am J Manag Care. 2016 Jan;22(1):28-34
pubmed: 26799122
J Pharm Pract. 2016 Aug;29(4):368-73
pubmed: 25634012
BMC Health Serv Res. 2017 Nov 13;17(1):722
pubmed: 29132369
JAMA Intern Med. 2018 Mar 1;178(3):375-382
pubmed: 29379953
Am J Health Syst Pharm. 2018 May 1;75(9):e221-e230
pubmed: 29691265
Am J Med Qual. 2018 Nov/Dec;33(6):583-589
pubmed: 29745236
J Hosp Med. 2016 Jan;11(1):39-44
pubmed: 26434752
South Med J. 2015 Dec;108(12):758-60
pubmed: 26630899
Ann Intern Med. 2011 Oct 18;155(8):520-8
pubmed: 22007045
Res Social Adm Pharm. 2015 Jul-Aug;11(4):517-30
pubmed: 25586885
J Manag Care Pharm. 2013 Sep;19(7):558-63
pubmed: 23964617